Steve Swenson

850 total citations
19 papers, 658 citations indexed

About

Steve Swenson is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Steve Swenson has authored 19 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Genetics and 4 papers in Oncology. Recurrent topics in Steve Swenson's work include Venomous Animal Envenomation and Studies (5 papers), Glioma Diagnosis and Treatment (3 papers) and Protease and Inhibitor Mechanisms (3 papers). Steve Swenson is often cited by papers focused on Venomous Animal Envenomation and Studies (5 papers), Glioma Diagnosis and Treatment (3 papers) and Protease and Inhibitor Mechanisms (3 papers). Steve Swenson collaborates with scholars based in United States, Cuba and Canada. Steve Swenson's co-authors include Frank Markland, Heinz‐Josef Lenz, Robert J. Morgan, Dongyun Yang, Lynda D. Roman, Hal W. Hirte, Gini F. Fleming, Helen Chen, Sidney Scudder and Susan Groshen and has published in prestigious journals such as Journal of Clinical Oncology, Journal of neurosurgery and International Journal of Cancer.

In The Last Decade

Steve Swenson

19 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steve Swenson United States 11 289 258 217 107 107 19 658
Chia‐Yen Huang Taiwan 16 232 0.8× 294 1.1× 228 1.1× 44 0.4× 68 0.6× 38 757
Germana Tognon Italy 18 264 0.9× 740 2.9× 333 1.5× 88 0.8× 152 1.4× 38 1.2k
Wanja Kildal Norway 14 214 0.7× 92 0.4× 149 0.7× 60 0.6× 188 1.8× 37 625
Jianqing Zhu China 16 206 0.7× 294 1.1× 318 1.5× 31 0.3× 91 0.9× 91 746
Hiromitsu Yabushita Japan 14 213 0.7× 144 0.6× 117 0.5× 67 0.6× 63 0.6× 50 579
Thaïs Baert Belgium 16 149 0.5× 558 2.2× 400 1.8× 66 0.6× 86 0.8× 47 955
Charles Schweizer United States 13 146 0.5× 170 0.7× 332 1.5× 84 0.8× 208 1.9× 24 703
Babak Litkouhi United States 16 167 0.6× 192 0.7× 243 1.1× 65 0.6× 88 0.8× 39 697
Jaspreet Singh Grewal United States 12 153 0.5× 165 0.6× 354 1.6× 94 0.9× 84 0.8× 46 654
Louisa Nelson United Kingdom 14 287 1.0× 90 0.3× 257 1.2× 35 0.3× 29 0.3× 23 625

Countries citing papers authored by Steve Swenson

Since Specialization
Citations

This map shows the geographic impact of Steve Swenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Swenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Swenson more than expected).

Fields of papers citing papers by Steve Swenson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Swenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Swenson. The network helps show where Steve Swenson may publish in the future.

Co-authorship network of co-authors of Steve Swenson

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Swenson. A scholar is included among the top collaborators of Steve Swenson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Swenson. Steve Swenson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Schönthal, Axel H., Steve Swenson, Phillip A. Bonney, et al.. (2022). Detection of perillyl alcohol and its metabolite perillic acid in postsurgical glioblastoma tissue after intranasal administration of NEO100: illustrative case. Journal of Neurosurgery Case Lessons. 4(8). 6 indexed citations
3.
4.
Schönthal, Axel H., Steve Swenson, Hye Na Kim, et al.. (2021). Potentially Curative Therapeutic Activity of NEO212, a Perillyl Alcohol-Temozolomide Conjugate, in Preclinical Cytarabine-Resistant Models of Acute Myeloid Leukemia. Cancers. 13(14). 3385–3385. 3 indexed citations
5.
Cho, Hee‐Yeon, Steve Swenson, Weijun Wang, et al.. (2020). Pharmacokinetic properties of the temozolomide perillyl alcohol conjugate (NEO212) in mice. Neuro-Oncology Advances. 2(1). vdaa160–vdaa160. 12 indexed citations
6.
Swenson, Steve, et al.. (2019). Cytotoxic impact of a perillyl alcohol–temozolomide conjugate, NEO212, on cutaneous T-cell lymphoma in vitro. Therapeutic Advances in Medical Oncology. 11. 3862506607–3862506607. 10 indexed citations
7.
Jadvar, Hossein, Kai Chen, Ryan J. Park, et al.. (2019). Preclinical evaluation of a 64Cu-labeled disintegrin for PET imaging of prostate cancer. Amino Acids. 51(10-12). 1569–1575. 5 indexed citations
8.
Wang, Weijun, Steve Swenson, Hee‐Yeon Cho, et al.. (2019). Efficient brain targeting and therapeutic intracranial activity of bortezomib through intranasal co-delivery with NEO100 in rodent glioblastoma models. Journal of neurosurgery. 132(3). 959–967. 13 indexed citations
9.
Swenson, Steve, Weijun Wang, Anupam Singh, et al.. (2018). NEO412: A temozolomide analog with transdermal activity in melanoma in vitro and in vivo. Oncotarget. 9(97). 37026–37041. 6 indexed citations
10.
Swenson, Steve, et al.. (2018). A Novel Venom-Derived Peptide for Brachytherapy of Glioblastoma: Preclinical Studies in Mice. Molecules. 23(11). 2918–2918. 14 indexed citations
11.
Lawrenson, Kate, Barbara Grün, Nathan Lee, et al.. (2014). NPPB is a novel candidate biomarker expressed by cancer‐associated fibroblasts in epithelial ovarian cancer. International Journal of Cancer. 136(6). 1390–1401. 26 indexed citations
12.
Levine, Michael, Steve Swenson, Taylor McCormick, et al.. (2012). Reversal of Thienopyridine-Induced Platelet Dysfunction Following Desmopressin Administration. Journal of Medical Toxicology. 9(2). 139–143. 12 indexed citations
13.
Zhang, Changhong, Mark E. Thompson, Frank Markland, & Steve Swenson. (2011). Chemical surface modification of parylene C for enhanced protein immobilization and cell proliferation. Acta Biomaterialia. 7(10). 3746–3756. 28 indexed citations
14.
Markland, Francis S. & Steve Swenson. (2010). Fibrolase: Trials and Tribulations. Toxins. 2(4). 793–808. 24 indexed citations
15.
Sánchez, Eladio F. & Steve Swenson. (2007). Proteases from South American Snake Venoms Affecting Fibrinolysis. Current Pharmaceutical Analysis. 3(2). 147–157. 13 indexed citations
16.
García, Agustin A., Hal W. Hirte, Gini F. Fleming, et al.. (2007). Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia. Journal of Clinical Oncology. 26(1). 76–82. 433 indexed citations
17.
Wang, Weijun, Jason P. Chua, Steve Swenson, et al.. (2005). Retargeting of adenoviral vector using basic fibroblast growth factor ligand for malignant glioma gene therapy. Journal of neurosurgery. 103(6). 1058–1066. 24 indexed citations
18.
Pyrko, Peter, Weijun Wang, Francis S. Markland, et al.. (2005). The role of contortrostatin, a snake venom disintegrin, in the inhibition of tumor progression and prolongation of survival in a rodent glioma model. Journal of neurosurgery. 103(3). 526–537. 7 indexed citations
19.
Bolger, Michael B., Steve Swenson, & Francis S. Markland. (2001). Three-dimensional structure of fibrolase, the fibrinolytic enzyme from southern copperhead venom, modeled from the x-ray structure of adamalysin II and atrolysin C. Europe PMC (PubMed Central). 3(2). 78–90. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chia‐Yen Huang Breakdown of academic impact, for papers by Germana Tognon Breakdown of academic impact, for papers by Wanja Kildal Breakdown of academic impact, for papers by Jianqing Zhu Breakdown of academic impact, for papers by Hiromitsu Yabushita Breakdown of academic impact, for papers by Thaïs Baert Breakdown of academic impact, for papers by Charles Schweizer Breakdown of academic impact, for papers by Babak Litkouhi Breakdown of academic impact, for papers by Jaspreet Singh Grewal Breakdown of academic impact, for papers by Louisa Nelson
Rankless by CCL
2026